RiGD

RiGD is funded by a grant from the Medical Research Council to CI Tim Cheetham and team.

It aims to examine whether the effects of rituximab increase the likelihood of Graves' hyperthyroidism resolving in young people, when administered in association with an abbreviated course of standard Carbimazole treatment.

You can find out more from RiGD’s registration on ISRCTN.